Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Ciro Costagliola, Mario Sbordone, Stefano Gandolfi, Luca Cesari, Gianluca Furneri & Antonio Maria Fea. (2020) Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?. Clinical Ophthalmology 14, pages 2639-2655.
Read now
Read now
Karen Walsh & Lyndon Jones. (2019) The use of preservatives in dry eye drops. Clinical Ophthalmology 13, pages 1409-1425.
Read now
Read now
Maria Fernanda Delgado, Ahmed Mostafa Abdelrahman, Malika Terahi, Juan Jose Miro Quesada Woll, Felix Gil-Carrasco, Colin Cook, Mohamed Benharbit, Sebastien Boisseau, Ernestine Chung, Yacine Hadjiat & José AP Gomes. (2019) Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement. ClinicoEconomics and Outcomes Research 11, pages 591-604.
Read now
Read now
Louis Tong, Eri Matsuura, Miki Takahashi, Takashi Nagano & Kouichi Kawazu. (2019) Effects of Anti-Glaucoma Prostaglandin Ophthalmic Solutions on Cultured Human Corneal Epithelial Cells. Current Eye Research 44:8, pages 856-862.
Read now
Read now
Alison Ng, Adam Keech & Lyndon Jones. (2018) Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops. Clinical Ophthalmology 12, pages 695-700.
Read now
Read now
Jayant Venkatramani Iyer, Yang Zhao, Fiona Pin Miao Lim, Louis Tong & Tina Tzee Ling Wong. (2017) Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis. Clinical Ophthalmology 11, pages 1191-1196.
Read now
Read now
Emily M. Schehlein, Mona A. Kaleem, Ramya Swamy & Osamah J. Saeedi. (2017) Microinvasive glaucoma surgery: an evidence-based assessment. Expert Review of Ophthalmology 12:4, pages 331-343.
Read now
Read now
Jie Shen & Marina Bejanian. (2016) Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose–response phenomenon. Clinical Ophthalmology 10, pages 373-383.
Read now
Read now
María de los Angeles Ramos-Cadena & George L. Spaeth. (2016) Ocular surface disease and glaucoma. Expert Review of Ophthalmology 11:3, pages 215-226.
Read now
Read now
Gábor Holló & Andreas Katsanos. (2015) Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma. Expert Opinion on Drug Safety 14:4, pages 609-617.
Read now
Read now
Julian Garcia-Feijoo & Juan Roberto Sampaolesi. (2012) A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma. Clinical Ophthalmology 6, pages 441-446.
Read now
Read now
Anastasios GP Konstas, Luciano Quaranta & Tony Realini. (2012) Overview of the BAK-free travoprost/timolol BAK-free fixed combination. Expert Opinion on Pharmacotherapy 13:5, pages 757-766.
Read now
Read now
Articles from other publishers (66)
E. N. Eskina, A. V. Belogurova & V. S. Zinina. (2023) Effectiveness and tolerability of the fixed combination of preservative-free drugs timolol and travoprost in glaucoma patients after cataract surgery. National Journal glaucoma 22:3, pages 45-51.
Crossref
Crossref
Ashley Shuen Ying Hong, Bryan Chin Hou Ang, Emily Dorairaj & Syril Dorairaj. (2023) Premium Intraocular Lenses in Glaucoma—A Systematic Review. Bioengineering 10:9, pages 993.
Crossref
Crossref
Victoria Toumanidou, Asterios Diafas, Nikolaos Georgiadis & Ioannis Tsinopoulos. (2023) Fixed versus Unfixed Combination of Topical Latanoprost/Timolol for Glaucoma: An Observational Study Investigating the Level of Adherence and Ocular Surface Health. Journal of Clinical Medicine 12:9, pages 3137.
Crossref
Crossref
Ka Wai Kam, Antonio Di Zazzo, Chiara De Gregorio, Purvasha Narang, Vishal Jhanji & Sayan Basu. (2023) A review on drug-induced dry eye disease. Indian Journal of Ophthalmology 71:4, pages 1263-1269.
Crossref
Crossref
Adem SOYDAN, Abdulgani KAYMAZ, Erol AYAZ, Kerem YAMAN, Mücahit ÇAKMAK, Abdullah BAYRAK & Metin OKŞAR. (2023) Investigation of the Relationship Between Chronic Use of Topical Antiglaucomatous Drops and Ocular Demodex InfestationTopikal Antiglokomatöz Damlaların Kronik Kullanımı İle Oküler Demodeks Enfestasyonu Arasındaki İlişkinin Araştırılması. Journal of Contemporary Medicine 13:2, pages 225-228.
Crossref
Crossref
Yujia Zhou, Andrew M. Philip, Max N. Chikovsky, John Nolan & Stephen D. Anesi. (2023) Implantation of XEN gel stent in a patient with ocular cicatricial pemphigoid. American Journal of Ophthalmology Case Reports 29, pages 101801.
Crossref
Crossref
Isaac Arias-Serrano, Paolo A. Velásquez-López, Laura N. Avila-Briones, Fanny C. Laurido-Mora, Fernando Villalba-Meneses, Andrés Tirado-Espin, Jonathan Cruz-Varela & Diego Almeida-Galárraga. (2023) Artificial intelligence based glaucoma and diabetic retinopathy detection using MATLAB — retrained AlexNet convolutional neural network. F1000Research 12, pages 14.
Crossref
Crossref
Luca Agnifili, Matteo Sacchi, Michele Figus, Chiara Posarelli, Rosario Alfio Umberto Lizzio, Paolo Nucci & Leonardo Mastropasqua. (2022) Preparing the ocular surface for glaucoma filtration surgery: an unmet clinical need. Acta Ophthalmologica 100:7, pages 740-751.
Crossref
Crossref
Janika Nättinen, Ulla Aapola, Praveena Nukareddy & Hannu Uusitalo. (2022) Clinical Tear Fluid Proteomics—A Novel Tool in Glaucoma Research. International Journal of Molecular Sciences 23:15, pages 8136.
Crossref
Crossref
Miguel de la Fuente, Iñaki Rodríguez-Agirretxe, Elena Vecino, Egoitz Astigarraga, Arantxa Acera & Gabriel Barreda-Gómez. (2022) Elevation of Tear MMP-9 Concentration as a Biomarker of Inflammation in Ocular Pathology by Antibody Microarray Immunodetection Assays. International Journal of Molecular Sciences 23:10, pages 5639.
Crossref
Crossref
Jeong Yeub Kim & Jae Woo Kim. (2022) Effect of the Preservative Benzalkonium Chloride in Prostaglandin Analogues on Corneal Sensitivity. Journal of the Korean Ophthalmological Society 63:3, pages 295-300.
Crossref
Crossref
Mauricio Aguirre Baez & Rodrigo Castillo Iturria. 2022. Dry Eye Syndrome - Modern Diagnostic Techniques and Advanced Treatments. Dry Eye Syndrome - Modern Diagnostic Techniques and Advanced Treatments.
Miraf Sahlu & Abeba T. Giorgis. (2021) Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia. BMC Ophthalmology 21:1.
Crossref
Crossref
Omer Ersin Muz, Kenan Dagdelen, Tuncay Pirdal & Mete Guler. (2021) Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension. International Ophthalmology 41:11, pages 3825-3835.
Crossref
Crossref
Philippe Denis, Susana Duch, Enping Chen, Per Klyve, Jesper Skov, Païvi Puska & Carl Erb. (2020) European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment. European Journal of Ophthalmology 31:3, pages 1056-1063.
Crossref
Crossref
Martina Janderová, Aleš Filouš, Martin Hložánek, Dagmar Dotřelová & Gabriela Mahelková. (2021) The Effect of Therapy on the Ocular Surface in Patients with Unilateral Paediatric Glaucoma. Czech and Slovak Ophthalmology 77:1, pages 28-34.
Crossref
Crossref
Emmanuel Kobia-Acquah, Gloria Atta-Penkra Gyekye, Ellen K. Antwi-Adjei, Nana Y. Koomson, Francis Cobbina, Richard Donkor & Prince K. Akowuah. (2021) Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana. Journal of Glaucoma 30:2, pages 180-186.
Crossref
Crossref
Ioannis Halkiadakis, Anna Vernikou, Vasilis Tzimis, Ioannis Markopoulos, Korina Popeskou & Vasiliki Konstadinidou. (2021) Assessment of Corneal Epithelium Thickness in Glaucomatous Patients Undergoing Medical Treatment. Journal of Glaucoma 30:1, pages 44-49.
Crossref
Crossref
Anastasios G. Konstas, Leopold Schmetterer, Andreas Katsanos, Cindy M. L. Hutnik, Gábor Holló, Luciano Quaranta, Miguel A. Teus, Hannu Uusitalo, Norbert Pfeiffer & L. Jay Katz. (2020) Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future. Advances in Therapy 38:1, pages 24-51.
Crossref
Crossref
Adam Muzychuk, Louis RacineMarie-Claude RobertCatherine Birt, Victor Penner, Paul Harasymowycz, Andrew Crichton, Bryce Ford, Patrick Gooi & Mona Harissi-Dagher. (2020) Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists. Journal of Glaucoma 29:12, pages 1162-1172.
Crossref
Crossref
Yeo-Yang Koh, Chi-Chin Sun & Ching-Hsi Hsiao. (2020) Epidemiology and the Estimated Burden of Microbial Keratitis on the Health Care System in Taiwan: A 14-Year Population-Based Study. American Journal of Ophthalmology 220, pages 152-159.
Crossref
Crossref
Pier Marino, Gemma Rossi, Giuseppe Campagna, Decio Capobianco & Ciro Costagliola. (2020) Effects of Citicoline, Homotaurine, and Vitamin E on Contrast Sensitivity and Visual-Related Quality of Life in Patients with Primary Open-Angle Glaucoma: A Preliminary Study. Molecules 25:23, pages 5614.
Crossref
Crossref
D.A. Dorofeev, A.V. Kryzhanovskaya & A.Z. Ciganov. (2020) Effectiveness of antihypertensive conservative-free therapy with fixed combination of bimatoprost and timolol (intermediate results). Vestnik oftal'mologii 136:2, pages 73.
Crossref
Crossref
T. Shaarawy & A. Aref. 2020. Oculoplastic Surgery. Oculoplastic Surgery
381
387
.
Abayomi Fabunmi & Steven R. SarkisianJrJr. (2019) Update on the Use of Premium Intraocular Lenses in Glaucoma. Current Ophthalmology Reports 7:3, pages 182-186.
Crossref
Crossref
Kanika Jain, Madhu Bhoot & Suneeta Dubey. (2019) Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self Report Assessment, and Keratograph Analysis. Journal of Glaucoma 28:5, pages e89-e90.
Crossref
Crossref
Xueli Chen & Yi Dai. 2019. Medical Treatment of Glaucoma. Medical Treatment of Glaucoma
177
187
.
Renata C. Portela, Nikoly T. Fares, Lilian F. Machado, Amanda F. São Leão, Denise de Freitas, Augusto Paranhos, Tiago S. Prata & Carolina P.B. Gracitelli. (2018) Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis. Journal of Glaucoma 27:9, pages 794-801.
Crossref
Crossref
Laura M. Dutca, Danielle Rudd, Victor Robles, Anat Galor, Mona K. Garvin & Michael G. Anderson. (2018) Effects of sustained daily latanoprost application on anterior chamber anatomy and physiology in mice. Scientific Reports 8:1.
Crossref
Crossref
Aaron B.C. Wong, Michael T.M. Wang, Kevin Liu, Zak J. Prime, Helen V. Danesh-Meyer & Jennifer P. Craig. (2018) Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye. The Ocular Surface 16:3, pages 289-293.
Crossref
Crossref
Kenji Kashiwagi & Mio Matsubara. (2018) Reduction in Ocular Hypotensive Eyedrops by Ab Interno Trabeculotomy Improves Not Only Ocular Surface Condition But Also Quality of Vision. Journal of Ophthalmology 2018, pages 1-8.
Crossref
Crossref
Ngamkae RuangvaravatePinnita PrabhasawatVirunya VachirasakchaiRatchadaporn Tantimala. (2018) High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand. Journal of Ocular Pharmacology and Therapeutics 34:5, pages 387-394.
Crossref
Crossref
N. V. Makashova, A. E. Vasilieva & O. Yu. Kolosova. (2018) Effects of artificial tears on ocular surface in glaucomatous patients with long-term instillation of preserved antiglaucoma eye drops. Vestnik oftal'mologii 134:2, pages 59.
Crossref
Crossref
Gábor Holló, Andreas Katsanos, Kostas G. Boboridis, Murat Irkec & Anastasios G. P. Konstas. (2017) Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. Drugs 78:1, pages 39-64.
Crossref
Crossref
Tevfik OĞUREL, Reyhan OĞUREL, Murat ATABEY ÖZER & Zafer ONARAN. (2017) Antiglokomatöz İlaç Kullanan Glokom Hastalarında Oküler Yüzey Hastalığının DeğerlendirilmesiEvaluation of Ocular Surface Disease in Glaucoma Patients Using Topical Antiglaucomatous Agents. Acta Medica Alanya 1:3, pages 116-121.
Crossref
Crossref
Vanessa Andrés-Guerrero, Irene Bravo-Osuna, Pilar Pastoriza, Irene T. Molina-Martinez & Rocío Herrero-Vanrell. (2017) Novel technologies for the delivery of ocular therapeutics in glaucoma. Journal of Drug Delivery Science and Technology 42, pages 181-192.
Crossref
Crossref
Francisco Pérez-Bartolomé, Jose M. Martínez-de-la-Casa, Pedro Arriola-Villalobos, Cristina Fernández-Pérez, Vicente Polo & Julián García-Feijoó. (2017) Ocular Surface Disease in Patients under Topical Treatment for Glaucoma. European Journal of Ophthalmology 27:6, pages 694-704.
Crossref
Crossref
Antonio Di ZazzoGloria RobertiAlireza MashaghiTulio Batista AbudDaniela PaveseStefano Bonini. (2017) Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications. Journal of Ocular Pharmacology and Therapeutics 33:9, pages 670-677.
Crossref
Crossref
Raffaele Nuzzi & Federico Tridico. (2017) Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis. Frontiers in Neuroscience 11.
Crossref
Crossref
Lyndon Jones, Laura E. Downie, Donald Korb, Jose M. Benitez-del-Castillo, Reza Dana, Sophie X. Deng, Pham N. Dong, Gerd Geerling, Richard Yudi Hida, Yang Liu, Kyoung Yul Seo, Joseph Tauber, Tais H. Wakamatsu, Jianjiang Xu, James S. Wolffsohn & Jennifer P. Craig. (2017) TFOS DEWS II Management and Therapy Report. The Ocular Surface 15:3, pages 575-628.
Crossref
Crossref
José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Nathan Efron, Masatoshi Hirayama, Jutta Horwath-Winter, Terry Kim, Jodhbir S. Mehta, Elisabeth M. Messmer, Jay S. Pepose, Virender S. Sangwan, Alan L. Weiner, Steven E. Wilson & James S. Wolffsohn. (2017) TFOS DEWS II iatrogenic report. The Ocular Surface 15:3, pages 511-538.
Crossref
Crossref
Sang Yeop Lee, Hun Lee, Hyoung Won Bae, Tae-im Kim & Chan Yun Kim. (2016) Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use. Optometry and Vision Science 93:10, pages 1210-1217.
Crossref
Crossref
Anhtuan H. Nguyen, Anna I. Dastiridou, Gloria B. Chiu, Brian A. Francis, Olivia L. Lee & Vikas Chopra. (2016) Glaucoma surgical considerations for PROSE lens use in patients with ocular surface disease. Contact Lens and Anterior Eye 39:4, pages 257-261.
Crossref
Crossref
Billie Beckwith-Cohen, Ellison Bentley, David J. Gasper, Gillian J. McLellan & Richard R. Dubielzig. (2015) Keratitis in six dogs after topical treatment with carbonic anhydrase inhibitors for glaucoma. Journal of the American Veterinary Medical Association 247:12, pages 1419-1426.
Crossref
Crossref
Hsin-Yi Chen, Cheng-Li Lin, Yi-Yu Tsai & Chia-Hung Kao. (2015) Association between Glaucoma Medication Usage and Dry Eye in Taiwan. Optometry and Vision Science 92:9, pages e227-e232.
Crossref
Crossref
Norlina Ramli, Gowri Supramaniam, Amir Samsudin, Azida Juana, Mimiwati Zahari & May May Choo. (2015) Ocular Surface Disease in Glaucoma. Optometry and Vision Science 92:9, pages e222-e226.
Crossref
Crossref
Karsten Voss, Karen Falke, Arne Bernsdorf, Niels Grabow, Christian Kastner, Katrin Sternberg, Ingo Minrath, Thomas Eickner, Andreas Wree, Klaus-Peter Schmitz, Rudolf Guthoff, Martin Witt & Marina Hovakimyan. (2015) Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment. Journal of Controlled Release 214, pages 1-11.
Crossref
Crossref
Katsuyoshi Suzuki, Shinichiro Teranishi, Takeshi Sagara, Hideaki Yoshino, Masako Nakayama, Miho Enoki, Yoshihisa Nuno, Shinji Hirano, Makiko Wakuta, Norihisa Takahashi, Kayoko Tokuhisa, Yukiko Kondo, Rie Shiraishi, Yasuhito Ishida & Koh-Hei Sonoda. (2015) Safety and Efficacy of Benzalkonium Chloride-optimized Tafluprost in Japanese Glaucoma Patients With Existing Superficial Punctate Keratitis. Journal of Glaucoma 24:6, pages e145-e150.
Crossref
Crossref
Gerard Callejo, Aida Castellanos, Marta Castany, Arcadi Gual, Carolina Luna, M. Carmen Acosta, Juana Gallar, Jonathan P. Giblin & Xavier Gasull. (2015) Acid-sensing ion channels detect moderate acidifications to induce ocular pain. Pain 156:3, pages 483-495.
Crossref
Crossref
Clement C. Y. Tham, Dexter Y. L. Leung, Yolanda Y. Y. Kwong, Yuanbo Liang, Andrea Yi Peng, Felix C. H. Li, Jimmy S. M. Lai & Dennis S. C. Lam. (2015) Factors Correlating With Failure to Control Intraocular Pressure in Primary Angle-Closure Glaucoma Eyes With Coexisting Cataract Treated by Phacoemulsification or Combined Phacotrabeculectomy. Asia-Pacific Journal of Ophthalmology 4:1, pages 56-59.
Crossref
Crossref
Hyoung Won Bae, Ji Hyun Kim, Sangah Kim, Minkyo Kim, Naeun Lee, Samin Hong, Gong Je Seong & Chan Yun Kim. (2015) Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients – A randomized, double-blind, placebo-controlled study. Journal of Ginseng Research 39:1, pages 7-13.
Crossref
Crossref
Ivan Goldberg, Rafael Gil Pina, Aitor Lanzagorta-Aresti, Rhett M Schiffman, Charlie Liu & Marina Bejanian. (2014) Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial. British Journal of Ophthalmology 98:7, pages 926-931.
Crossref
Crossref
Anthony J. Bron, Alan Tomlinson, Gary N. Foulks, Jay S. Pepose, Christophe Baudouin, Gerd Geerling, Kelly K. Nichols & Michael A. Lemp. (2014) Rethinking Dry Eye Disease: A Perspective on Clinical Implications. The Ocular Surface 12:2, pages S1-S31.
Crossref
Crossref
Luís Abegão Pinto, Evelien Vandewalle, Laetitia Gerlier & Ingeborg Stalmans. (2014) Improvement in Glaucoma Patient Quality of Life by Therapy Switch to Preservative-Free Timolol/Dorzolamide Fixed Combination. Ophthalmologica 231:3, pages 166-171.
Crossref
Crossref
Sevda Aydin Kurna, Semih Acikgoz, Ahmet Altun, Nurver Ozbay, Tomris Sengor & Osman Okan Olcaysu. (2014) The Effects of Topical Antiglaucoma Drugs as Monotherapy on the Ocular Surface: A Prospective Study. Journal of Ophthalmology 2014, pages 1-8.
Crossref
Crossref
Murat Irkec, Banu Bozkurt & Mehmet Cem Mocan. (2013) Are preservatives necessary to improve efficacy of some glaucoma drops?. British Journal of Ophthalmology 97:12, pages 1493-1494.
Crossref
Crossref
Norihiko YokoiLara Borrego-SanzJosé A Gegúndez-FernándezJosé M Benítez-del-Castillo. 2013. Dry Eye Syndrome: Basic and Clinical Perspectives. Dry Eye Syndrome: Basic and Clinical Perspectives
8
19
.
Gemma Caterina Maria RossiGian Maria PasinettiLuigia ScudellerPaolo Emilio Bianchi. (2013) Ocular Surface Disease and Glaucoma: How to Evaluate Impact on Quality of Life. Journal of Ocular Pharmacology and Therapeutics 29:4, pages 390-394.
Crossref
Crossref
Sangmoon Lee, Mee Kum Kim, Hyuk Jin Choi, Won Ryang Wee & Dong Myung Kim. (2013) Comparative Cross-sectional Analysis of the Effects of Topical Antiglaucoma Drugs on the Ocular Surface. Advances in Therapy 30:4, pages 420-429.
Crossref
Crossref
Snježana Kaštelan, Martina Tomić, Kata Metež Soldo & Jasminka Salopek-Rabatić. (2013) How Ocular Surface Disease Impacts the Glaucoma Treatment Outcome. BioMed Research International 2013, pages 1-7.
Crossref
Crossref
Fleur O'Hare, Gary Rance, Allison M McKendrick & Jonathan G Crowston. (2012) Is primary open‐angle glaucoma part of a generalized sensory neurodegeneration? A review of the evidence. Clinical & Experimental Ophthalmology 40:9, pages 895-905.
Crossref
Crossref
Fateme Alipour, Ahmad Kheirkhah & Mahmoud Jabarvand Behrouz. (2012) Use of mini scleral contact lenses in moderate to severe dry eye. Contact Lens and Anterior Eye 35:6, pages 272-276.
Crossref
Crossref
Joshua C. Teichman, Steven D. Vold & Iqbal Ike K. Ahmed. (2012) Top 5 Pearls for Implanting Premium IOLs in Patients With Glaucoma. International Ophthalmology Clinics 52:2, pages 65-71.
Crossref
Crossref
Flavio Mantelli, Laura Tranchina, Alessandro Lambiase & Stefano Bonini. (2011) Ocular surface damage by ophthalmic compounds. Current Opinion in Allergy & Clinical Immunology 11:5, pages 464-470.
Crossref
Crossref
Alessandro Bagnis, Marina Papadia, Riccardo Scotto & Carlo E. Traverso. (2011) Antiglaucoma drugs: The role of preservative-free formulations. Saudi Journal of Ophthalmology 25:4, pages 389-394.
Crossref
Crossref
Charles S. Tressler, Richard Beatty & Michael A. Lemp. (2011) Preservative Use in Topical Glaucoma Medications. The Ocular Surface 9:3, pages 140-158.
Crossref
Crossref